SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
cas12049-sup-0001-TableS1.docWord document148KTable S1. Relation between non-tumor β1, 6-N-acetylglucosaminyltransferase V (MGAT5) expression and clinical characteristics in the training set and validation set.
cas12049-sup-0002-TableS2.docWord document119KTable S2. Univariate Cox regression analyses for overall survival in three independent sets.
cas12049-sup-0003-TableS3.docWord document78KTable S3. Multivariate Cox regression analyses for overall survival in three independent sets.
cas12049-sup-0004-TableS4.docWord document43KTable S4. Log–rank test on overall survival for non-tumor β1, 6-N-acetylglucosaminyltransferase V (MGAT5) expression in the training set and validation set.
cas12049-sup-0005-TableS5.docWord document111KTable S5. Log–rank test on overall survival in three independent sets of gastric cancer subtypes.
cas12049-sup-0006-FigureS1.tifimage/tif3021KFig. S1. Kiel proposal of stage grouping and TNM classification of gastric cancer.
cas12049-sup-0007-FigureS2.tifimage/tif8982KFig. S2. β1, 6-N-acetylglucosaminyltransferase V (MGAT5) antibody specificity in human gastric cancer cells.
cas12049-sup-0008-FigureS3.tifimage/tif2894KFig. S3. Optimal cut-off value of β1, 6-N-acetylglucosaminyltransferase V (MGAT5) immunoreactivity scoring was obtained by receiver operating characteristic analysis.
cas12049-sup-0009-FigureS4.tifimage/tif2187KFig. S4. Comparison of overall survival in gastric cancer patients according to non-tumor β1, 6-N-acetylglucosaminyltransferase V (MGAT5) expression.
cas12049-sup-0010-FigureS5.tifimage/tif4175KFig. S5. Analysis of overall survival according to the expression of intratumoral β1, 6-N-acetylglucosaminyltransferase V (MGAT5) in patients with late-stage gastric cancer.
cas12049-sup-0011-FigureS6.tifimage/tif2826KFig. S6. Kaplan–Meier analyses for overall survival according to intratumoral β1, 6-N-acetylglucosaminyltransferase V (MGAT5) expression in patients of gastric cancer with differential human epidermal growth factor receptor 2 (HER2) classification.
cas12049-sup-0012-FigureS7.tifimage/tif2845KFig. S7. Kaplan–Meier analyses for overall survival according to intratumoral β1, 6-N-acetylglucosaminyltransferase V (MGAT5) expression in patients of gastric cancer with differential histological types.
cas12049-sup-0013-FigureS8.tifimage/tif2819KFig. S8. Kaplan–Meier analyses for overall survival according to intratumoral β1, 6-N-acetylglucosaminyltransferase V (MGAT5) expression in patients of gastric cancer with differential Lauren classification.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.